Clinical trial
S-1 and Irinotecan Combination Chemotherapy for Advanced Gastric Cancer
NCT00343668 · Korean Cancer Study Group, Other · Unknown status
Key facts
| NCT number | NCT00343668 |
|---|---|
| Title | S-1 and Irinotecan Combination Chemotherapy for Advanced Gastric Cancer |
| Official title | A Phase II Study of S-1 and Irinotecan Combination Chemotherapy in Patients With Advanced Gastric Cancer as a First-Line Therapy |
| Lead sponsor | Korean Cancer Study Group, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Gastric Cancer |
| Intervention type | Drug |
| Interventions | S-1, irinotecan |
| Enrollment | 44 |
| Start date | Sep 1, 2005 |
| Primary completion | Mar 1, 2007 |
| Completion | Jul 1, 2008 |
| First posted | Jun 23, 2006 |
| Last update posted | May 26, 2010 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: